Related Experiment Video
Updated: Aug 17, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
[Prognosis and therapy of malignant non-Hodgkin's lymphoma]
Abstract:
Rarely low malignant Non-Hodgkin-lymphomas (NHL) can be attended curatively. An alternative to hitherto applied chemotherapy in advanced stages is the retarded therapeutic proceeding in the so-called "indolent" NHL. However, the optimal therapeutic regimen is unknown. High malignant NHL can be attended curatively to a high percentage. With protocols of therapy in 2. and 3. generation the total remission rate could be increased and the rate of relapses could be decreased compared with the CHOP-scheme. The application of radiotherapy is not defined sufficiently in high malignant NHL yet.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy

